Mangoceuticals (MGRX) Enterprise Value (2023 - 2026)

Mangoceuticals has disclosed Enterprise Value across 4 years of filings, most recently posting $6.6 million for Q2 2026.

• In Q2 2026, Enterprise Value fell 58.91% year-over-year to $6.6 million; the TTM figure through Jun 2026 stood at $6.6 million (down 58.91% YoY), while the FY2025 annual figure was $5.9 million, up 25.86% from the prior year.
• Enterprise Value came in at $6.6 million for Q2 2026 at Mangoceuticals, up from $5.9 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $27.6 million in Q2 2023 to a low of $3.7 million in Q4 2023.
• Average Enterprise Value over 4 years is $10.5 million, with a median of $7.9 million recorded in 2024.
• Year-over-year, Enterprise Value slumped 69.73% in 2024 and soared 231.39% in 2025.
• Over 4 years, Enterprise Value stood at $3.7 million in 2023, then grew by 27.18% to $4.7 million in 2024, then rose by 25.86% to $5.9 million in 2025, then increased by 11.26% to $6.6 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $6.6 million in Q2 2026, $5.9 million in Q1 2026, and $5.9 million in Q4 2025.